Focus: Hidden - Houston Metro

• share
• favorite_border

John Mendelsohn, M.D., president emeritus of The University of Texas MD Anderson Cancer Center and an internationally acclaimed leader in the field of medicine and scientist whose research helped pioneer a new type of cancer therapy, died Jan. 7 at his home in Houston. He was 82. The cause of death was glioblastoma, an aggressive form of brain cancer with which he was diagnosed 15 months ago.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center and Nanobiotix today announced a large-scale, comprehensive clinical research collaboration to evaluate innovative strategies for treating patients with head and neck, pancreatic, thoracic, lung, gastrointestinal and genitourinary cancers, with the first trials to be launched in 2019.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center and Ascentage Pharma Group, Inc. today announced a five-year strategic collaboration agreement to advance the development of five potential new cancer therapies.

• share
• favorite_border

The University of Texas MD Anderson Cancer Center and 4D pharma today announced a strategic collaboration to evaluate 4D’s live biotherapeutic oncology pipeline across a range of cancer settings.

• share
• favorite_border

Waun Ki Hong, M.D., a trail-blazing physician-scientist and mentor whose clinical research innovations led to successful organ-sparing cancer treatment, advanced the field of targeted therapy and launched chemoprevention, died Wednesday at his home in California. Hong, 76, retired from The University of Texas MD Anderson Cancer Center as head of the Division of Cancer Medicine in 2014. He remained as a special advisor to a variety of MD Anderson programs that nurtured the careers of young scientists.

• share
• favorite_border

Researchers have long known that sick children can affect a company's bottom line, as employees are distracted or have to take time off to care for their children. Far less is known about the impact a parent's work life has on their children's health.

• share
• favorite_border

New year, new you – the pressure to be the best version of yourself builds in January, including the need to be comfortable in your own skin. That’s why experts at The University of Texas Health Science Center at Houston (UTHealth) are sharing their top tips on improving how your skin looks and feels both now and in the future.

• share
• favorite_border

The late Stephen Hawking famously didn't believe in God. Neither does the renowned Richard Dawkins. But is that typical for U.K. scientists?

• share
• favorite_border

For many, the holiday season is a time of overeating, but a Houston Methodist personal trainer says this year you can beat the battle of the bulge by using the classic tune “The 12 Days of Christmas.”

• share
• favorite_border

With the holiday party season in full swing, deciding what to wear can be the biggest headache. But paying attention to what you eat at such occasions might reveal it’s your diet more in need of a makeover. The good news is experts at The University of Texas Health Science Center at Houston (UTHealth) can help.

• share
• favorite_border

Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC).

• share
• favorite_border

A follow-up analysis of patients enrolled in a Phase I/II multi-center trial for diffuse large B-cell lymphoma (DLBCL) reported 51 percent of patients receiving an anti-CD19 chimeric antigen receptor (CAR T) called axi-cel were still alive two years post-treatment. The study, co-led by Sattva Neelapu, M.D., professor of Lymphoma & Myeloma at The University of Texas MD Anderson Cancer Center, reported its findings in the Dec. 2 online issue of The Lancet Oncology and during a presentation at the 60th American Society of Hematology Annual Meeting & Exposition in San Diego.

• share
• favorite_border

Breast cancer survivors who used a smartphone app created at Houston Methodist consistently lost weight, largely due to daily, real-time interactions with their health care team via the mobile app.

• share
• favorite_border

Emergency medicine physicians at The University of Texas Health Science Center at Houston (UTHealth) are seeking community input about a proposed clinical trial assessing the efficacy of inhaling xenon, a medical gas, to mitigate brain injury and preserve cerebral function in cardiac arrest patients.

• share
• favorite_border

A new clinical trial at The University of Texas Health Science Center at Houston (UTHealth) is the first in the world to investigate whether infusing an infant’s own umbilical cord blood cells, or autologous cells, can protect the brain, mitigating the risk of neurodevelopmental challenges in babies with severe congenital diaphragmatic hernia (CDH).

• share
• favorite_border

Millions of Americans have no idea that they have fatty liver disease. This growing problem will soon be the number one reason for liver transplantation, overtaking hepatitis C. Holiday overindulgence in alcohol and food could make the problem dramatically worse.

• share
• favorite_border

Two leaders in the field of melanoma treatment – a surgeon and an oncologist – from The University of Texas MD Anderson Cancer Center have been named Fellows of the American Association for the Advancement of Science (AAAS).

• share
• favorite_border

The temptation to overindulge at Thanksgiving is immense, but before going overboard, it’s worth pausing and remembering you can eat, drink, and be merry – as well as healthy – over the holiday season.

• share
• favorite_border

Research on a new way of deploying the immune system against pancreatic cancer, an exceptionally lethal cancer that has so far resisted new immunotherapies, will receive $1 million in initial funding from Stand Up to Cancer. The project led by researchers from The University of Texas MD Anderson Cancer Center and Baylor College of Medicine will collect T cells – the immune system’s targeted warriors -- from tumors, expand their number by the billions and then customize them to resist being shut down by a common substance that’s abundantly produced in tumor tissue

• share
• favorite_border

Flaring issues vary across the U.S. with complex regulatory, economic and infrastructure frameworks. A team comprised of researchers from the Houston Advanced Research Center (HARC) and the Research Partnership to Secure Energy for America (RPSEA) will evaluate the current state of technologies and regulatory and economic environments, to identify technical and economic solutions for further investigation and demonstration.